- Buisan, O., Servian, P., Pedreño-Lopez, S., Pagès, J., Urrea, V., Martínez, R., Garcia, E., Cardona, P.-J., Vilaplana, C., Amat, M., Areal, J., Bellmunt, J., Clotet, B., & Cabrera, C. (2025). A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non–muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. European Urology. https://doi.org/10.1016/j.eururo.2025.08.014 (En premsa)
A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non–muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial
on 7 d'abril de 2026
with No hi ha comentaris
Deixa un comentari